A1ZN34:BVMF
AstraZeneca
139,90 BRL
0,00%
(0,00) 1 D
16. okt., 17:06:00 GMT-3 · BRL
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for A1ZN34 …
Åpne
143,33 BRL
Høy
143,33 BRL
Lav
138,81 BRL
Markedsverdi
259,42 mrd.
Snittvolum
892,00
Volum
1,25k
52 u høy
190,40 BRL
52 u lav
129,06 BRL
Utestående aksjer
1,55 mrd.
Antall ansatte
96k
Åpne
143,33 BRL
Høy
143,33 BRL
Lav
138,81 BRL
Markedsverdi
259,42 mrd.
Snittvolum
892,00
Volum
1,25k
52 u høy
190,40 BRL
52 u lav
129,06 BRL
Utestående aksjer
1,55 mrd.
Antall ansatte
96k
Nyhetssaker
Fra nettkilder og nyhetspartnere
Insider Monkey
·
for 11 timer siden
AstraZeneca’s Shares Have Fallen, but Is 14.6x Forward Earnings a Buying Opportunity?
JournalArta
·
for 1 døgn siden
AstraZeneca Stock Analysis: Gains 3.24%, Testing Key Resistance
Reuters
·
for 1 døgn siden
AstraZeneca strikes $40 million AI drug discovery deal with insitro
Fox Business
·
for 1 døgn siden
AstraZeneca, Insitro strike AI drug discovery deal
Profil
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
Om AstraZeneca
Administrerende direktørPascal Soriot
Ansatte96,1k
Grunnlagt6. apr. 1999
HovedkontorCambridge, Cambridgeshire, Storbritannia
Sektor-
Nettstedastrazeneca.com